This study evaluated safety and tolerability of ubrogepant for acute treatment of migraine in participants taking atogepant for preventive treatment of episodic migraine (EM).
No takes yet. Share an insight, caveat, or question.
Brand‐Schieber et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: